Betaseron® and Extavia® are taken by injection
Betaseron® and Extavia® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).
Betaseron and Extavia are approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of MS to reduce the frequency of clinical exacerbations. Relapsing forms of MS include individuals with secondary-progressive MS who continue to experience relapses or acute attacks. Betaseron and Extavia are also approved for use in individuals who have experienced a first clinical episode (clinically-isolated syndrome) and have MRI features that are consistent with multiple sclerosis.
Click here to read the FDA Prescribing Information for Betaseron.
Click here to read the FDA Medication Guide for patients.
Click here to read the FDA Prescribing Information for Extavia.
Click here to read the FDA Medication Guide for Extavia
BETAPLUSTM Support Program
Financial Assistance Program
BETAPLUSTM FINANCIAL SUPPORT